Leaflet QUADRIXAM 5mg / 1.25mg / 5mg / 5mg capsules

Product code:: W72012001
Quantity:: 30
Indicated for:: hypertension in adults already controlled with the same four substances at equivalent doses; substitution treatment
Route of administration:: oral
Substance:: perindopril + indapamide + amlodipine + bisoprolol (ACE inhibitor+thiazide-like diuretic+calcium channel blocker+beta blocker)
ATC: C09BX06 — Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors, other combinations

Precautions:

Take this medicine on an empty stomach.

This medicine may affect your ability to drive or use machines.

Dose adjustment may be needed in kidney disease.

This medicine may cause dizziness or vertigo.

Use caution if you have glaucoma or increased eye pressure.

Read the package leaflet before use.

Do not use this medicine during pregnancy.

Avoid grapefruit and grapefruit juice.

Avoid excessive exposure to sunlight or UV radiation.

May lower blood pressure and increase the risk of falls.

This medicine may have important interactions with other medicines.

Periodic laboratory tests may be required during treatment.

Use during breastfeeding only on medical advice.

Use in children only as recommended in the leaflet or by a doctor.

Older people may have an increased risk of side effects.

This medicine may increase the risk of heart rhythm disturbances.

This medicine may affect fetal development.

Do not stop treatment abruptly without medical advice.

This medicine may change blood electrolyte levels.

Substance:: perindopril + indapamide + amlodipine + bisoprolol
Date of latest medicines list:: 01-08-2026
Product code:: W72012001
Concentration:: 5mg / 1.25mg / 5mg / 5mg
Pharmaceutical form:: capsules
Quantity:: 30
Product type:: Generic medicine
Prescription status:: P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.